Orbus Pharma Inc. (TSX:ORB) (“Orbus”) today announced that they have entered into a development, manufacture and supply agreement with ratiopharm inc., of Mississauga, Ontario, to develop and supply a generic product used in the treatment of depression for the Canadian market.
